Sale!

The Antidote: Inside the World of New Pharma

Amazon.com Price:  $10.25 (as of 12/05/2019 16:46 PST- Details)

Description

In this timely and much praised book, Barry Werth draws upon inside reporting that spans more than two decades. He provides a groundbreaking close-up of the upstart pharmaceutical company Vertex and the ferocious but indispensable world of Big Pharma that it inhabits.

In 1989, the charismatic Joshua Boger left Merck, then The united states’s most admired business, to found a drug company that would challenge industry giants and develop into health care. Werth described the company’s tumultuous early days throughout the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex’s bold endurance and eventual success.

The $325 billion-a-year pharmaceutical business is The united states’s toughest and one of its most profitable. It’s riskier and more rigorous at with reference to each and every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears the entire hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating on the planet’s most regulated industry, matched only by nuclear power.

Werth captures the full scope of Vertex’s twenty-five-year drive to deliver breakthrough medicines. At a time when The united states struggles to handle its innovative edge, The Antidote is a powerful inside look at one of the crucial intriguing and important business stories of latest decades.

Home » Shop » Books » Subjects » Science and Math » Biological Sciences » Biotechnology » The Antidote: Inside the World of New Pharma

Recent Products